Telesis Bio, Inc.
TBIO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $27,509 | $27,435 | $11,043 | $6,576 |
| % Growth | 0.3% | 148.4% | 67.9% | – |
| Cost of Goods Sold | $10,559 | $11,840 | $6,744 | $2,951 |
| Gross Profit | $16,950 | $15,595 | $4,299 | $3,625 |
| % Margin | 61.6% | 56.8% | 38.9% | 55.1% |
| R&D Expenses | $17,496 | $23,460 | $14,548 | $8,925 |
| G&A Expenses | $21,090 | $22,131 | $14,229 | $4,130 |
| SG&A Expenses | $34,604 | $38,620 | $25,125 | $11,061 |
| Sales & Mktg Exp. | $13,514 | $16,489 | $10,958 | $6,931 |
| Other Operating Expenses | $11,389 | $0 | $0 | $0 |
| Operating Expenses | $63,489 | $62,080 | $39,673 | $19,986 |
| Operating Income | -$46,539 | -$46,485 | -$35,374 | -$16,361 |
| % Margin | -169.2% | -169.4% | -320.3% | -248.8% |
| Other Income/Exp. Net | -$1,161 | -$1,962 | -$3,570 | -$1,644 |
| Pre-Tax Income | -$47,700 | -$48,447 | -$38,944 | -$18,005 |
| Tax Expense | $24 | $24 | $14 | $5 |
| Net Income | -$47,724 | -$48,471 | -$38,958 | -$18,010 |
| % Margin | -173.5% | -176.7% | -352.8% | -273.9% |
| EPS | -1.59 | -1.65 | -1.33 | -0.62 |
| % Growth | 3.6% | -24.1% | -114.5% | – |
| EPS Diluted | -1.59 | -1.65 | -1.33 | -0.62 |
| Weighted Avg Shares Out | 29,930 | 29,463 | 29,319 | 29,229 |
| Weighted Avg Shares Out Dil | 29,930 | 29,463 | 29,319 | 29,229 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,743 | $738 | $0 | $0 |
| Interest Expense | $3,105 | $1,955 | $1,369 | $690 |
| Depreciation & Amortization | $4,102 | $2,875 | $1,574 | $1,457 |
| EBITDA | -$40,493 | -$43,617 | -$36,001 | -$15,858 |
| % Margin | -147.2% | -159% | -326% | -241.1% |